Materialise has beaten earnings four quarters in a row and has a perfect Piotroski score with steady mid-single-digit revenue growth, but the stock is 13.4% above the analyst target and near its 52-week high.
Thesis pillars
- Steady Revenue Growth↓Deteriorating
- Perfect Earnings Beat Streak↓Deteriorating
- Strong Financial Health Score→Stable
- +2 more pillars — see the Why tab for full reasoning
Pillars as of Oct 24, 2026
Materialise NV (MTLS) Stock Analysis
Technology · Software - Application
Wait for pullback to $8.50. Price sits above the model's entry target of $8.50; the risk/reward becomes favorable on a pullback. Key risks: Analyst target reached - limited upside remaining; Near 52-week high (1.9% away).
Materialise NV provides additive manufacturing and medical software tools, and 3D printing services in the Americas, Europe, Africa, and the Asia-Pacific. The company operates through three segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. The... Read more
Wait for pullback to $8.50. Price sits above the model's entry target of $8.50; the risk/reward becomes favorable on a pullback. Key risks: Analyst target reached - limited upside remaining; Near 52-week high (1.9% away). Chart setup: No clear chart pattern; technical signals are mixed. Earnings in 1 day. Wait until post-earnings. Score 5.2/10, high confidence.
Passes 6/8 gates (positive momentum, clean insider activity, no SEC red flags, news events none recent, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio and earnings proximity 1d<=7d. Suitability: aggressive.
Recent developments
updated 2026-10-27Recent Developments — Materialise NV
Latest news
- NEWS Materialise resumes stock buyback plan effective Aug. 31 - scanx.trade — scanx.trade positive
- NEWS MTLS261016P00007500 Interactive Stock Chart | MTLS Oct 2026 7.500 put Stock - Yahoo Finance — Yahoo Finance neutral
- NEWS Issuance/retirement of debt (net) of Materialise NV – EURONEXT:MTLS - TradingView — TradingView neutral
- NEWS MATERIALISE : SHARE-BUY BACK PROGRAM - www.marketscreener.com — www.marketscreener.com positive
- NEWS After +1.62% Gain, Is Materialise (MTLS) Still a Value Play? 2026-10-26 - Initial Balance - www.dars.gov.et — www.dars.gov.et positive
Generated 2026-10-27T11:58:34Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
10 dimensions · all in-band
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Wait for pullback to $8.50. Price sits above the model's entry target of $8.50; the risk/reward becomes favorable on a pullback. Key risks: Analyst target reached - limited upside remaining; Near 52-week high (1.9% away). Chart setup: No clear chart pattern; technical signals are mixed. Earnings in 1 day. Wait until post-earnings. Analyst target $7.45 reached (−13.9%), stop $8.04 (−7.6%), A.R:R -1.6:1. Score 5.2/10, high confidence.
Analyst target $7.45 reached (−13.9% from $8.65); no take-profit level is published. Analyst target $7.45 reached (−13.9%), stop $8.04 (−7.6%), A.R:R -1.6:1. Stop-loss: $8.04.
Analyst target reached - limited upside remaining; Near 52-week high (1.9% away); V7 low-quality RISK_OFF penalty: -0.5 (Q=5.0).
Materialise NV trades at a P/E of 30.9 (forward 33.5). TrendMatrix value score: 5.3/10. Verdict: Buy (Wait for Entry).
9 analysts cover MTLS with a consensus score of 4.1/5. Average price target: $9.
What does Materialise NV do?Materialise NV provides additive manufacturing and medical software tools, and 3D printing services in the Americas,...
Materialise NV provides additive manufacturing and medical software tools, and 3D printing services in the Americas, Europe, Africa, and the Asia-Pacific. The company operates through three segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. The Materialise Software segment offers proprietary software through programs and platforms that enable and enhance the functionality of 3D printers, and printing operations. Its software interfaces between various types of 3D printers; and various software applications and capturing technologies, including computer-aided design/computer-aided manufacturing packages and 3D scanners; a MES, software providers. This segment serves 3D printing machine manufacturers; production companies and contract manufacturers in automotive, aerospace, consumer goods, and hearing aid industries; and 3D printing service bureaus through its sales force, website, and third-party distributors. The Materialise Medical segment provides medical software that allows medical-image based analysis, planning, and engineering, as well as patient-specific design and printing of surgical devices and implants. It serves medical device companies, hospitals, universities, research institutes, and industrial companies. The Materialise Manufacturing segment provides 3D printing services, design and engineering services, and rapid prototyping and additive manufacturing of production parts to customers serving the automotive, consumer goods industrial goods, semiconductor, art and architecture and aerospace markets. The company has collaboration agreements with Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Smith & Nephew Inc.; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc. Materialise NV was incorporated in 1990 and is headquartered in Leuven, Belgium.